



Universidad Nacional de La Plata
Argentina
Protective role of chlorogenic acid on
DNA damage caused by ochratoxin A
exposure
Campra, Noelia Anahí; Cariddi, Laura Noelia; Escobar, Franco Matías; Sabini, María Carola; Freire-de-Lim,
Celio Geraldo; Decote-Ricardo, Debora; Roma, Dardo; Mañas, Fernando; Dalcero, Ana María
Protective role of chlorogenic acid on DNA damage caused by ochratoxin A exposure
ANALECTA VETERINARIA, vol. 40, no. 2, 2020
Universidad Nacional de La Plata, Argentina
Atribución no comercial sin derivar (CC BY-NC-ND) 4.0
PDF generated from XML JATS4R
https://doi.org/10.24215/15142590e049 
ANALECTA VETERINARIA, vol. 40, 
no. 2, 2020
Universidad Nacional de La Plata, 
Argentina
Received: 08 June 2020 
Revised: 06 August 2020 




Protective role of chlorogenic acid on DNA damage caused 
by ochratoxin A exposure
Rol protector del ácido clorogénico sobre el daño del ADN causado por la exposición a ocratoxina A
           Campra, Noelia Anahí #   
Instituto de Biotecnología Ambiental y Salud (INBIAS) CONICET-
Universidad Nacional de Río Cuarto, Argentina
Cariddi, Laura Noelia #  
lcariddi@exa.unrc.edu.ar 
Instituto de Biotecnología Ambiental y Salud (INBIAS) CONICET-
Universidad Nacional de Río Cuarto
Escobar, Franco Matías
CONICET-Universidad Nacional de Río Cuarto, Argentina
Sabini, María Carola 
Freire-de-Lima, Celio Geraldo 
Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brasil 
Decote-Ricardo, Debora 
Instituto de Veterinária, Universidade Federal Rural do Rio de Janeiro, Brasil
Roma, Dardo 
Cátedra de Farmacología, Universidad Nacional de Río Cuarto, Argentina
Mañas, Fernando 
Cátedra de Farmacología, Universidad Nacional de Río Cuarto, Argentina
Ana María Dalcero
Departamento de Microbiología e Inmunología, Universidad Nacional de Río Cuarto, 
Argentina
Abstract
Chlorogenic acid (ChlA) has shown short-term protective effects against the cyto-
genotoxic effects of ochratoxin A (OTA). e present study evaluated the effect of oral 
administration of ChlA in male Wistar rats exposed to OTA. OTA (0.4 mg/kg bw/
day), ChlA (5 mg/kg bw/day), or the combination of both, were administered orally to 
animals during 28 days. No deaths, decrease in feed consumption or change in the body 
weight of animals were observed in any group. In the OTA-treated group a decrease in 
locomotion as well as increased DNA damage in blood, kidney and bone marrow cells 
were observed. ChlA alone was not genotoxic for animals. e combination of OTA
+ChlA decreased the DNA damage by 37% in blood cells, by 55% in kidney cells and 
by 80% in bone marrow cells compared to OTA-treated group. In conclusion, oral 
treatment with ChlA showed a good protective effect on genotoxicity produced by 
OTA in rats during 28 days exposure.
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Resumen 
El ácido clorogé nico (ChlA) mostró efectos protectores a corto plazo contra los efectos 
citogenotóxicos de ocratoxina A (OTA). En el presente estudio se evaluó si este 
polifenol mantiene su efecto protector mediante la administración oral en ratas 
Wistar machos expuestas a OTA. OTA (0,4 mg/kg/día), ChlA (5 mg/kg/día), o la 
combinación de ambos, fueron administrados a los animales por vía oral durante 28 
días. No se observaron muertes, ni disminución en el consumo de alimento, ni cambios 
en el peso corporal en ningún grupo de animales. En el grupo tratado con OTA se 
observó disminución en la locomoción, así como daño en el ADN en las cé lulas de 
sangre, riñó n y mé dula ósea. En los animales que solo recibieron ChlA no se 
observaron efectos genotóxicos. La combinación de OTA + ChlA disminuyó el daño 
del ADN en un 37%en las cé lulas sanguíneas, en un 55% en las cé lulas renales y en un 
80% en las cé lulas de la mé dula ósea con respecto al grupo tratado con OTA. En 
conclusión, el tratamiento oral con ChlA mostró buen efecto protector sobre la 
genotoxicidad producida por OTA en ratas durante 28 días de exposición.
Palabras clave: ocratoxina A, genotoxicidad, ácido clorogé nico.
Introduction
Ochratoxin A (OTA) is a toxic secondary metabolite produced by 
species of filamentous fungi of the genera Penicillium and Aspergillus, 
which grow on a wide range of organic substrates. is mycotoxin is 
present mainly in cereals for human consumption and animal feed as well 
as in alcoholic beverages, coffee and cocoa (Ravelo Abreu et al., 2011). 
Generally, monogastric and younger animals are more sensitive t o 
mycotoxins than ruminant or older animals. e high ingestion of 
mycotoxins can cause deterioration of animal health as well as decreased 
production. Mycotoxicosis occurs with decrease in feed consumption 
and increase in morbidity and mortality rates (Muzaffer & Pérez, 2006).
e nephrotoxic, hepatotoxic, embryotoxic, teratogenic, neurotoxic, 
immunotoxic, genotoxic, and carcinogenic effects of OTA have already 
been demonstrated (Wang et al., 2020).
Polyphenols constitute one of the largest groups of non-energetic 
substances present in plants and foods of plant origin, with antioxidant 
properties that account for many of their beneficial effects (Quiñones et 
al., 2012). Different studies report that the toxic effects of mycotoxins 
could be reduced by polyphenols (Mazur-Kuśnirek et al., 2019). 
Chlorogenic acid (ChlA) is an important antioxidant polyphenol which 
is found in certain plants and is the main phenolic compound in coffee 
(Tajik et al., 2017). e protective effect of ChlA on cyto-genotoxicity 
induced by different toxic substances has been reported (Carranza-
Torres e t al., 2019). A previous study reported the short-term protective 
effects of ChlA on DNA damage induced by OTA in Balb/c mice aer 
24 hours of intraperitoneal treatment (Cariddi et al., 2015). e present 
study a imed to determine the possible protective effect of orally 
administered ChlA on DNA damage in rats exposed to OTA for 28 days 
by means of micronucleus assays in bone marrow cells and comet assays 
in blood and kidney cells.
2ANALECTA VETERINARIA, vol. 40, no. 2, 2020
Campra et al. Chlorogenic acid and its effect on ochratoxin A
ANALECTA VETERINARIA, 2020, 40(2), Julio-Diciembre, ISSN: 1514-2590 
Materials and methods
Reagents
Ochratoxin A was purchased from BioPure Technology (UK); 
dimethylsulfoxide (DMSO) was obtained from Merck (Germany) and 
chlorogenic acid (≥ 95%) was purchased from Sigma St. Louis, (USA).
e doses of OTA (0.4 mg/kg bw/day) and ChlA (5 mg/kg bw/day) 
used, were based on a previous study (Cariddi et al., 2016). OTA and 
ChlA were dissolved in DMSO Merck (Germany)/phosphate buffered 
solution (PBS) (solvent concentration not exceeding 0.03%).
Experimental animals and treatments
All experimental procedures were conducted in accordance with recent 
legislation. is study was approved by the Comité de Ética de la 
Investigación Científica (COEDI), Universidad Nacional de Río Cuarto 
(File No. 73/12) Male Wistar rats were used. e trials were performed 
with male rats because of their high susceptibility to OTA renal damage 
(Vettorazzi et al., 2014). Ten to twelve week old male Wistar rats 
(weighing 150-200 g), supplied from Bioterio of the Universidad Nacional 
de Río Cuarto, were maintained in a temperature and humidity controlled 
room, with 12 hours light-dark cycles and food and water ad libitum. 
Briefly, animals were randomly divided into four groups (four animals per 
group; n=4) and treated individually by daily intragastric gavage during 
28 days as follows: group 1: 0.2 ml/day DMSO/PBS (Vehicle Control 
Group), group 2: OTA (0.4 mg/kg bw/day; OTA), group 3: ChlA (5 
mg/kg bw/day; ChlA), and group 4: a combination of OTA (0.4 mg/
kg bw/day) and ChlA (5 mg/kg bw/day; OTA+ChlA). On day 29, 
animals were euthanized and blood samples were collected immediately 
with heparin for comet assay. e kidneys were dissected and stored at 
-20 °C until further analysis by comet assay and the femurs were excised 
for micronucleus assay.
Toxicity parameters
e animals were examined once daily in order to observe toxicity
reactions (hunched posture, waggling gait, decreased locomotion,
aggressive behavior) and feed consumption. Body weight was recorded
once a week.
Comet assay for blood samples
e heparinized blood samples were kept in the dark at 4 °C and 
processed within 6 hours. e comet assay was performed as described by 
Cariddi et al. (2015).
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Comet assay for kidney samples
Frozen kidney tissues were thawed at room temperature during 
preparation, and placed in cylindrical sieves which were filled with 1.5 
ml ice-cold Merchant's medium (0.14 M NaCl, 1.47 mM KH2PO4, 2.7 
mM KCl, 8.1 mM Na2HPO4, 10 mM Na2EDTA, pH 7.4) e comet 
assay was performed according to the protocol proposed by Jackson et al. 
(2013). Tissues were homogenized by pressing through sieves as the 
plunger was moved up and down several times to obtain a cell 
suspension. e cells were trypsinized and suspended in PBS at a density 
of approximately 1×105 cells/ml. A 50 µl aliquot of each cell suspension 
was added to 100 µl of 0.75% low melting point agarose at 37 °C. e 
mixtures were layered onto slides pre-coated with 0.75% normal melting 
point agarose and covered with a coverslip. From this point forward, the 
protocol was identical to that used for the comet assay on blood samples.
Micronucleus assay
e assay was performed in bone marrow cells following standard 
protocols described by Cariddi et al. (2015).
Results were evaluated using GraphPad Prism version 5.00.288 (San
Diego, USA, 2007) and compared with one-way analysis of variance
(ANOVA) and the Tukey multiple comparison test or Kruskal Wallis
test and Dunns multiple comparisons. e differences were considered to
be statistically significant at p<0.05.
Results
No deaths were recorded in any experimental group during the 28 days
of the in vivo assay. However, the OTA-treated group showed decreased
locomotion and overall less movement than other treatment groups. Rats
treated with ChlA, OTA+ChlA and DMSO/PBS did not show reactions
of toxicity. Neither decrease in feed consumption nor changes in body
weight gain of animals were observed in any group (Figures 1 A and B).
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Figure 1. A) Average daily body weight gain and B) Average daily feed consumption of Wistar rats in the 28 days of treatment with 
ochratoxin A (OTA), chlorogenic acid (ChlA) or combination of OTA+ ChlA. Four rats were used per experimental group. Each 
value represents means Â± SD. DMSO: dimethylsulfoxide. Statistical test: ANOVA and Tukey`s Test.
Figures 2 A and B show the results of the comet assay. In OTA-treated 
group an increase in tail moment of the blood and kidney cells 
compared to control group (p<0.001) was observed. However, 
treatment of the animals with OTA+ChlA produced a decrease in 
DNA damage by 37% in blood cells and by 55% in kidney cells 
(p<0.05) with respect to OTA. e micronucleus assay results are shown 
in Table 1. An increase i n the frequency of micronucleus (MN) in 
polychromatic erythrocytes (PCE) in OTA-treated group compared to 
control group (p<0.001) was observed. e frequency of MN in PCE 
was reduced by 80% with OTA+ChlA acid treatment compared to 
OTA-treated group (p<0.001). No differences were observed in the 
PCE/normochromatic erythrocytes (NCE) ratio in any group. Cellular 
DNA of animals treated with only Ch1A was not altered.
Figure 2. Protective effects of chlorogenic acid (ChlA) on ochratoxin A (OTA)-induced DNA damage (tail moment) measured by comet 
assay. A) blood cells or B) kidney cells from Wistar rats (n = 4) aî†er 28 days of treatment. Each value representhe means ± SD. 
Statistical test: Kruskal-Wallis and Dunns Test. c: p<0.05 compared with OTA group. 
5ANALECTA VETERINARIA, vol. 40, no. 2, 2020
Table 1. Protective effects of chlorogenic acid (ChlA) on ochratoxin A (OTA) induced genotoxic effects on bone 
marrow erythrocytes from Wistar rats after 28 days of treatment.
Four rats were used per experimental group; TI: Toxicity Index; GI: Genotoxicity Index; PCE: polychromatic 
erythrocytes; NCE: normochromatic erythrocytes; MNPCE: micronucleated polychromatic erythrocytes. Statistical 
test: ANOVA and Tukey`s Test. Different superscript letter indicates statistical significance.
Discussion
is work evaluated the protective effect of ChlA administered orally 
on DNA damage in Wistar rats exposed to OTA. Body weight is an 
important indicator of toxicity; however, this parameter was not altered 
in any treatment group. In a previous study we observed similar results 
(Cariddi et al., 2016). In the present study we reported the DNA 
damage induced by OTA on blood cells and bone marrow cells, as 
reported previously by our laboratory (Cariddi et al., 2015) as well as by 
other authors (Corcuera et al., 2015). We also found DNA damage in 
kidney cells of animals treated with OTA, as demonstrated by other 
researchers (Abdel-Wahhab et al. 2017). Some studies have related OTA 
damage in kidney with carcinogenicity (Tajik et al., 2017). e 
protective effect of ChlA on DNA damage induced by OTA was already 
demonstrated in a previous study (Cariddi et al., 2015). However, in 
that study both polyphenol and mycotoxin were administered 
intraperitoneally, and the protective effect was evaluated 24 hours post-
injection. In the present study, oral administration of ChlA during 28 
days in rats exposed to OTA also protected from the genotoxicity 
induced by this mycotoxin. Chlorogenic acid is a powerful natural 
antioxidant (Xu et al., 2012). In this study, oral treatment of rats with 
only ChlA did not alter DNA of cells. Other studies have also 
demonstrated the lack of toxicity of this compound (Wang et al., 2020). 
In a previous study in rats exposed to OTA we demonstrated that the 
oral administration of ChlA reversed the pathological damage induced 
by this mycotoxin in kidneys, as well as the biochemical parameters 
altered in urine and serum. However, we did not observe an increase in 
the oxidative stress parameters measured in kidneys of OTA-treated 
animals, indicating a protective effect of ChlA but not by an antioxidant 
mechanism (Cariddi et al., 2016). Although some studies report 
oxidative DNA damage induced by OTA in kidneys
Campra et al. Chlorogenic acid and its effect on ochratoxin A
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(Abdel-Wahhab et al., 2017), this is controversial because several 
authors demonstrated a lack of oxidative damage associated to the toxic 
effects caused by this mycotoxin (Kőszegi & Poór, 2016). e results 
suggest that ChlA could be protecting cellular DNA from the damage 
induced by OTA by a different mechanism.
In conclusion, oral treatment with ChlA decreased DNA damage 
induced by OTA exposure in blood, bone marrow and kidney cells 
showing a good protective activity that may be important for the 
prevention of ochratoxicosis in susceptible animals.
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